Please provide your email address to receive an email when new articles are posted on . The introduction of additional neflamapimod in an open-label extension led to significant clinical improvements.

After her mom's diagnosis of Lewy body dementia, a Lincoln woman said she noticed there was a lack of culturally diverse support options in Nebraska. Now, she's working to raise awareness and be part ...

A children’s book written in the shadow of a life-changing diagnosis is now being used to support dementia awareness.

(RTTNews) - CervoMed Inc. (CRVO) has announced positive 32-week data from the Extension phase of its phase IIb RewinD-LB trial of oral investigational drug Neflamapimod for the treatment of dementia ...

Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on neflamapimod treatment for DLB New data demonstrating ...

Researchers have pinpointed one of the brain’s “early warning signs” of dementia and Parkinson’s disease. According to the ...

She looked at me with tears in her eyes, and I said, “Isn’t it nice to love someone so much that saying goodbye is so hard?” Her face relaxed, as if through the disease she was able to grasp a moment ...

Please provide your email address to receive an email when new articles are posted on . In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association ...

Researchers have found compelling evidence that depression points to the development of Parkinson's disease or Lewy body ...

Late-onset depression may be an early sign of Parkinson’s disease (PD) or Lewy Body dementia (LBD), according to a December study published in General Psychiatry.